Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence of elevated liver stiffness in patients with type 1 and type 2 diabetes: A systematic review and meta-analysis
Stefano Ciardullo, Gianluca Perseghin
Diabetes Research and Clinical Practice (2022) Vol. 190, pp. 109981-109981
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment
Stefano Ciardullo, Michela Vergani, Gianluca Perseghin
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5597-5597
Open Access | Times Cited: 33
Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma
Marcin Kosmalski, Agnieszka Śliwińska, Józef Drzewoski
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1097-1097
Open Access | Times Cited: 25
Comparative efficacy of 5 sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor and 4 glucagon-like peptide-1 (GLP-1) receptor agonist drugs in non-alcoholic fatty liver disease: A GRADE-assessed systematic review and network meta-analysis of randomized controlled trials
Yunpeng Gu, Lei Sun, Wei Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 23
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2025
Nuha A. ElSayed, Rozalina G. McCoy, Grazia Aleppo, et al.
Diabetes Care (2024) Vol. 48, Iss. Supplement_1, pp. S59-S85
Closed Access | Times Cited: 11
Diabetes as a risk factor for MASH progression
Sofiya Gancheva, Michael Roden, Laurent Castéra
Diabetes Research and Clinical Practice (2024) Vol. 217, pp. 111846-111846
Open Access | Times Cited: 9
Making Sense of the Nonalcoholic Fatty Liver Disease Clinical Practice Guidelines: What Clinicians Need to Know
Kenneth Cusi, Jeff Budd, Eric L. Johnson, et al.
Diabetes Spectrum (2024) Vol. 37, Iss. 1, pp. 29-38
Open Access | Times Cited: 4
Time Trends in Liver-Related Mortality in People With and Without Diabetes: Results From a Population-Based Study
Stefano Ciardullo, Gabriella Morabito, Federico Rea, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 10, pp. 2513-2519
Open Access | Times Cited: 4
CXCL12 as a Potential Hub Gene for N-Acetylcysteine Treatment of T1DM Liver Disease
Menglong Zhao, Mingzheng Han, Sen Guo, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 176-176
Open Access
Metabolic dysfunction‐associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi‐centre cross‐sectional study
Michela Vergani, Nicolò Diego Borella, Maria Rosaria Rizzo, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Type 2 Diabetes Mellitus
Hüseyin Ali Öztürk, Erdinç Gülümsek, Dilan Damla Öztürk, et al.
Sakarya Medical Journal (2025) Vol. 15, Iss. 1, pp. 71-77
Open Access
Research progress of metformin in the treatment of liver fibrosis
Anqi Zhang, Fangyi Qian, Yangyang Li, et al.
International Immunopharmacology (2023) Vol. 116, pp. 109738-109738
Closed Access | Times Cited: 12
Healthy Eating Index-2015 in relation to risk of metabolic dysfunction-associated fatty liver disease among US population: National Health and Nutrition Examination Survey 2017–2018
Wei Zhang, Xinyue Wang, Jiale Huang, et al.
Frontiers in Nutrition (2023) Vol. 9
Open Access | Times Cited: 11
Differential Association of Sex Hormones with Metabolic Parameters and Body Composition in Men and Women from the United States
Stefano Ciardullo, Francesca Zerbini, Rosa Cannistraci, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4783-4783
Open Access | Times Cited: 11
Assessment of the Liver Steatosis and Fibrosis Risk in Metabolic Syndrome and Its Individual Components, Considering the Varying Definitions Used in Clinical Practice throughout Time: A Retrospective Cross-Sectional Study
Szymon Suwała, Roman Junik
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1739-1739
Open Access | Times Cited: 3
Green Coffee Bean Extract Potentially Ameliorates Liver Injury due to HFD/STZ-Induced Diabetes in Rats
Doaa M. Abdel-Mohsen, Ahmed M. A. Akabawy, Manal F. El‐Khadragy, et al.
Journal of Food Biochemistry (2023) Vol. 2023, pp. 1-16
Open Access | Times Cited: 7
Metabolic dysfunction-associated fatty liver disease in people living with HIV
Maurice Stephan Michel, Christian Labenz, Angelo Armandi, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Novel Dual Incretin Receptor Agonists in the Spectrum of Metabolic Diseases with a Focus on Tirzepatide: Real Game-Changers or Great Expectations? A Narrative Review
Alexandros L. Liarakos, Chrysi Koliaki
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1875-1875
Open Access | Times Cited: 7
The Cardiac-Kidney-Liver (CKL) syndrome: the “real entity” of type 2 diabetes mellitus
Niki Katsiki, Genovefa Kolovou, Αndreas Μelidonis, et al.
Archives of Medical Science (2024) Vol. 20, Iss. 1, pp. 207-215
Open Access | Times Cited: 2
Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes
Ebaa Al‐Ozairi, Mohammad Irshad, Jumana AlKandari, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 9, pp. 4052-4059
Open Access | Times Cited: 2
Liver stiffness is associated with all‐cause mortality in patients with NAFLD: A systematic review and meta‐analysis
Stefano Ciardullo, Emanuele Muraca, Francesca Zerbini, et al.
Liver International (2023) Vol. 43, Iss. 12, pp. 2604-2610
Open Access | Times Cited: 6
Gastrointestinal and Liver Complications in Patients with Diabetes Mellitus—A Review of the Literature
Ruxandra Mare, Ioan Sporea
Journal of Clinical Medicine (2022) Vol. 11, Iss. 17, pp. 5223-5223
Open Access | Times Cited: 9
Non-invasive prediction nomogram for predicting significant fibrosis in patients with metabolic-associated fatty liver disease: a cross-sectional study
Fan Zhang, Yan Han, Yong-Hua Mao, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 1
Noninvasive identification of probable fibrotic nonalcoholic steatohepatitis across the spectrum of glucose tolerance in the United States
Stefano Ciardullo, Marco Carbone, Pietro Luigi Invernizzi, et al.
Diabetes Research and Clinical Practice (2023) Vol. 199, pp. 110679-110679
Open Access | Times Cited: 4
The Association between Personality Factors and Metabolic Parameters among Patients with Non-Alcoholic-Fatty Liver Disease and Type 2 Diabetes Mellitus—A Cross-Sectional Study
Marcin Kosmalski, Rafał Frankowski, Monika Różycka-Kosmalska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4468-4468
Open Access | Times Cited: 3
Predictive Risk Factors of Nonalcoholic Fatty Liver Disease in a Lean Chinese Population
Lu Liu, Xiaolan Shi, Jingwen Gao, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 12, pp. 1958-1958
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top